Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus [NA]
This is a completed clinical trial update from Centre Hospitalier Universitaire Dijon. It reports on quality of life and activity in systemi…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment [Phase 2]
This Phase 2 study is evaluating the efficacy and safety of induction therapy combining belimumab and telitacicept in proliferative lupus ne…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating anti-CD19 CAR-T cell therapy for refractory systemic lupus erythematosus, including lupus nephritis…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: COVID-19 Booster and IIV Schedule in Immunocompromised Hosts [Phase 2]
Phase 2 clinical trial from McGill University Health Centre evaluating a COVID-19 booster and influenza vaccine schedule in immunocompromise…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study of GR1803 in Systemic Lupus Erythematosus [Phase 1, Phase 2]
Ongoing clinical trial update for GR1803 in systemic lupus erythematosus, spanning Phase 1 and Phase 2, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) [Phase 1]
A Phase 1 study evaluating CT1190B for moderate-to-severe refractory systemic lupus erythematosus or refractory/progressive systemic scleros…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus [Phase 1]
This update notes the completion of a Phase 1 study evaluating Telitacicept in children with childhood-onset systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease [Phase 1]
Phase 1 study update for FT819 in B-cell–mediated autoimmune diseases; recruitment is ongoing for ANCA-associated vasculitis, idiopathic inf…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase 1 safety study update for SG301-SC in systemic lupus erythematosus; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) [Phase 3]
A Phase 3 clinical trial evaluating ianalumab added to standard-of-care for systemic lupus erythematosus is currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
A Cairo University-led study is recruiting to evaluate nutritional status in rheumatic diseases and its association with disease activity ac…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) [Phase 3]
Novartis is conducting a Phase 3 trial (SIRIUS-SLE 1) to evaluate two regimens of ianalumab added to standard-of-care therapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Phone-Based Based Walk With Ease Program for Adults With Arthritis [NA]
Completed clinical trial evaluating a phone-based Walk With Ease program for adults with arthritis, with results posted.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a targeted CD19 or CD19-BCMA CAR-T therapy for autoimmune diseases is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone [NA]
A completed clinical trial evaluating a personalised approach to tapering corticosteroid doses in systemic lupus erythematosus patients trea…
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating CLBR001 and SWI019 in autoimmune diseases has been withdrawn from further development.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus [Phase 3]
Ongoing Phase 3 study evaluating the long-term safety and tolerability of Cenerimod in adults with systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]
Phase 1 trial update on YTS109 cell therapy for relapsed/refractory autoimmune diseases, currently recruiting across multiple indications.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study [EARLY_Phase 1]
Early Phase 1 clinical trial assessing the safety and potential efficacy of ES-NK cell injections for refractory lupus nephritis; the study …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 study update indicates Hangzhou Qihan Biotech is actively recruiting participants for a dual-target universal CAR-T cell therapy for…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 in pediatric relapsed/refractory autoimmune diseases, including SLE and diffuse systemic sclerosi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus [Phase 1]
Autolus Limited is conducting a Phase 1 trial of Obe-cel for severe, refractory systemic lupus erythematosus in adolescents (UK only) and ad…